Moderna <-bsp-bb-link state="{"bbDocId":"RH81CVDWRGG2","_id":"00000182-daa2-da0b-a1a3-fbbf9dd60003","_type":"0000016b-944a-dc2b-ab6b-d57ba1cc0000"}">accused-bsp-bb-link> Pfizer and BioNTech of violating intellectual property rights on key elements of its messenger RNA technology in developing the Comirnaty vaccine. Cambridge, Massachusetts-based Moderna said it had patents from 2010 to 2016 on the mRNA technology that made its Spikevax shot possible but that the other two companies copied the technology without permission.
Pfizer and BioNTech “took four different candidates into clinical testing, ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.